Purchase Order 75N93023P01277

Award Date 9/13/23
Potential Completion Date 9/12/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Carlsbad, CA 92008, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Active Motif, Inc., doing business as Active Motif, has been awarded a $13,080 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide RNA and end-to-end RNA sequencing services. The one-year contract, which runs from October 2023 through October 2024, will support NIAID's research efforts through the delivery of RNA and sequencing analysis services. Active Motif will perform the work as the prime contractor...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), awarded a $14,425.00 firm fixed price purchase order to Active Motif, Inc. for sequencing services. The contract has an ultimate completion date of November 2, 2024 and was not set aside for any specific business type. Active Motif, Inc. is a small disadvantaged business that provides innovative tools, antibodies, and sequencing services to support biomedical...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Active Motif, Inc., a small disadvantaged business manufacturer of goods, to provide custom DNA sequencing services. The contract is for 3 samples of "CBLX DISORDERQUANTITY" at $4,740.00 and 1 control sample at $1,750.00, for a total potential value of $15,970.00. The contract does not have a...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $61,975.00 firm fixed price purchase order contract to Active Motif, Inc. for Chromatin Immunoprecipitation (ChIP) sequence analysis services. This sole source contract was awarded without a set-aside designation under the authority of 41 U.S.C. 1901(e)(2) as only Active Motif could provide the required services. The contract supports the...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $23,850 purchase order to Novogene Corp Inc. to provide plant and animal eukaryotic mRNA sequencing services under Agricultural Marketing Service Blanket Purchase Agreement number 21833252. The firm fixed price contract runs from August 10, 2023 to October 31, 2023 and will be performed in Sacramento, California. No subcontractors or set aside designations...
This firm fixed-price purchase order awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Active Motif, Inc. is valued at $405,000. Under the terms of the contract, Active Motif will provide single-nuclei multiome analysis services for 50 samples of human brain tissue, induced pluripotent stem cell-derived cells, or human dorsal root ganglion as requested in Solicitation Number NCATS-23-0414. The solicitation sought these sequencing and data...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $16,345.50 purchase order to Biointron Biological USA Inc. for antibody expression services. As a firm fixed price contract, Biointron will provide the requested antibody expression services to NIH/NIAID at Metuchen, New Jersey from September 19, 2023 through December 29, 2023. No subcontractors or set aside designations were indicated. NIAID conducts and...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $24,191 purchase order to Nanostring Technologies, Inc. of Seattle, Washington. Under this firm fixed price contract, Nanostring will provide RNA consumables to support continued assay activity for the NIH/NIAID. No major subcontractors or set aside designations were indicated. This purchase order was awarded to support the NIH/NIAID's ongoing work...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,794.60 purchase order to Nanostring Technologies, Inc. of Seattle, Washington. Under the firm fixed price contract, Nanostring will provide GEOMX REAGENT KITS to support the agency's research efforts. The contract has a one year period of performance beginning September 2025 through September 2024. No set aside designation or subcontractors were indicated....
Tecan Genomics Inc. has been awarded an $11,782 purchase order contract by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to provide RNA sequencing kits. The firm fixed price contract has a period of performance starting on September 19, 2023 through December 29, 2023 for the kits to be delivered to the prime contractor's location in Redwood City, California. No set aside designation or subcontractors were...

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $13,080 firm fixed price purchase order to Active Motif, Inc. for an end-to-end RNA-seq service including bioinformatic analysis and custom assay involving RNA-seq sample submission in RLT buffer. As the prime contractor, Active Motif will perform the work out of its facilities in Carlsbad, California under a one-year period of performance through September 2024. No subcontractors or set aside designations were indicated. This supports the NIH-NIAID's research into human health issues like allergies and infectious diseases through genomic and molecular analysis techniques.

Generated 12/22/23, 7:13 PM